Runben Biotechnology Co., Ltd. (SHA:603193)

China · Delayed Price · Currency is CNY

19.65

+0.05 (0.26%)

Sep 15, 2026, 11:29 AM CST

Market Cap	7.93B -32.3%
Revenue (ttm)	1.70B +15.9%
Net Income	352.07M +14.4%
EPS	0.88 +15.7%
Shares Out	404.59M
PE Ratio	22.29
Forward PE	21.08
Dividend	0.46 (2.20%)
Ex-Dividend Date	May 29, 2026

Volume	1,196,200
Open	19.75
Previous Close	19.60
Day's Range	19.50 - 19.75
52-Week Range	17.77 - 30.00
Beta	0.17
Analysts	Strong Buy
Price Target	31.18 (+58.68%)
Earnings Date	Aug 21, 2026

About Runben Biotechnology

Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, infant care products, and essential oil products. The company also sells its products through online channels. Runben Biotechnology Co., Ltd. was founded in 1993 and is based in Guangzhou, China. [Read more]

Industry Household & Personal Products

Sector Consumer Staples

Founded 1993

Employees 1,018

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603193

Full Company Profile

Financial Performance

In 2025, Runben Biotechnology's revenue was 1.54 billion, an increase of 17.19% compared to the previous year's 1.32 billion. Earnings were 314.50 million, an increase of 4.78%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 603193 stock is "Strong Buy." The 12-month stock price target is ¥31.18, which is an increase of 58.68% from the latest price.

Price Target

¥31.18

(58.68% upside)

Analyst Consensus: Strong Buy

Stock Forecasts